Melissa Martin, MD, has been named CMO of NYC Health + Hospitals/Coler and Lucan Rodrigues, MD, has been named CMO of NYC Health + Hospitals/McKinney, according to a Dec. 19 news release from the ...

"In an ideal world, supply chain resiliency would encompass complete visibility through real-time tracking and of all supplies, diversified supply resources and advanced technology that automates ...

Fairview Park Hospital's CEO Don Avery announces retirement after 38 years in healthcare. Read his heartfelt letter and learn about the 190-bed facility's impa ...

1. The inpatient hospital is expected to open in 2027, according to a Dec. 18 news release from the health system. 2. The facility will feature private patient rooms, a therapy gym, an in-house ...

MedHQ, a healthcare advisory and administrative service provider, has named Erik Miller CEO, effective in early 2025.

A new study from the University of California San Diego School of Medicine found that applying Lean methodology to surgical residency programs reduces work hours and improves program efficiency. The ...

Hampton Roads, Va.-based Sentara Health has appointed Melinda Hancock executive vice president and CFO, effective Jan. 1. Ms. Hancock will succeed Robert Broermann, who is retiring in April, according ...

Charlotte, N.C.-based Atrium Health has shared plans to increase the minimum hourly wage for its North and South Carolina employees to $18.50 an hour, effective Jan. 12. Atrium Health is part of ...

In an interactive session at Becker's 12th Annual CEO + CFO Roundtable, two leaders from — Mike Kreitzinger, lead of health system strategy, and Damon Hostin, lead of market access for health systems ...

Tampa General Hospital will operate Lakeside Medical Center under a five-year agreement, a Tampa General spokesperson confirmed to Becker's. The Palm Beach County Health Care District's board of ...

Pharmacist sues HCA Healthcare for wrongful termination after LinkedIn post about staffing challenges leads to firing. Read more on Becker's.

Merck has entered into a global licensing agreement with Chinese biopharmaceutical company Hansoh Pharma to develop an oral small molecule GLP-1 receptor agonist, HS-10535.